Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

19,075 public trials 1,287 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

Dasatinib for HIV-1 Reservoir Reduction

NCT07342491

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Northwestern University CRS (Site # 2701) Chicago, Illinois, United States
  • 2501, Case CRS Cleveland, Ohio, United States
  • 1401, University of Washington Positive Research CRS Seattle, Washington, United States
View Trial Details
Recruiting

Study Evaluating the Efficacy and Safety of Artesunate

NCT06853184

Conditions
CMV Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Westmead Hospital Westmead, Australia
  • Princess Alexandra Hospital Woolloongabba, Australia
View Trial Details
Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

NCT07281430

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Louisiana State University Lafayette, Louisiana, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
View all 18 locations
View Trial Details
Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

NCT07069699

Conditions
Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details

Related conditions